| Product Code: ETC7277234 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Georgia Antiretroviral Therapy Market Overview |
3.1 Georgia Country Macro Economic Indicators |
3.2 Georgia Antiretroviral Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Georgia Antiretroviral Therapy Market - Industry Life Cycle |
3.4 Georgia Antiretroviral Therapy Market - Porter's Five Forces |
3.5 Georgia Antiretroviral Therapy Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 Georgia Antiretroviral Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Georgia Antiretroviral Therapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Georgia Antiretroviral Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Georgia Antiretroviral Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HIV/AIDS in Georgia |
4.2.2 Growing awareness about the benefits of antiretroviral therapy |
4.2.3 Government initiatives and funding to improve access to healthcare services |
4.3 Market Restraints |
4.3.1 High cost of antiretroviral drugs |
4.3.2 Limited healthcare infrastructure and resources |
4.3.3 Stigma associated with HIV/AIDS leading to delayed treatment initiation |
5 Georgia Antiretroviral Therapy Market Trends |
6 Georgia Antiretroviral Therapy Market, By Types |
6.1 Georgia Antiretroviral Therapy Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 Georgia Antiretroviral Therapy Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 Georgia Antiretroviral Therapy Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.4 Georgia Antiretroviral Therapy Market Revenues & Volume, By HIV Protease Inhibitors, 2021- 2031F |
6.1.5 Georgia Antiretroviral Therapy Market Revenues & Volume, By Non-nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.6 Georgia Antiretroviral Therapy Market Revenues & Volume, By Nucleotide Reverse Transcriptase Inhibitors, 2021- 2031F |
6.1.7 Georgia Antiretroviral Therapy Market Revenues & Volume, By HIV Fusion Inhibitors, 2021- 2031F |
6.1.8 Georgia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Georgia Antiretroviral Therapy Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Georgia Antiretroviral Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Georgia Antiretroviral Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Georgia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Georgia Antiretroviral Therapy Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Georgia Antiretroviral Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Georgia Antiretroviral Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Georgia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Georgia Antiretroviral Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Georgia Antiretroviral Therapy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Georgia Antiretroviral Therapy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Georgia Antiretroviral Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Georgia Antiretroviral Therapy Market Import-Export Trade Statistics |
7.1 Georgia Antiretroviral Therapy Market Export to Major Countries |
7.2 Georgia Antiretroviral Therapy Market Imports from Major Countries |
8 Georgia Antiretroviral Therapy Market Key Performance Indicators |
8.1 Average time from HIV diagnosis to antiretroviral therapy initiation |
8.2 Percentage of patients achieving viral suppression |
8.3 Number of healthcare facilities offering antiretroviral therapy services |
8.4 Adherence rate to antiretroviral therapy treatment plans |
8.5 Number of new antiretroviral therapy prescriptions issued |
9 Georgia Antiretroviral Therapy Market - Opportunity Assessment |
9.1 Georgia Antiretroviral Therapy Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 Georgia Antiretroviral Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Georgia Antiretroviral Therapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Georgia Antiretroviral Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Georgia Antiretroviral Therapy Market - Competitive Landscape |
10.1 Georgia Antiretroviral Therapy Market Revenue Share, By Companies, 2024 |
10.2 Georgia Antiretroviral Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |